Karyopharm Therapeutics Inc.
KPTI · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $37,672 | $38,725 | $38,783 | $62,476 |
| Short-Term Investments | $8,205 | $12,972 | $31,158 | $46,236 |
| Receivables | $31,877 | $32,932 | $35,243 | $30,766 |
| Inventory | $3,966 | $4,992 | $4,769 | $4,739 |
| Other Curr. Assets | $8,026 | $8,249 | $10,285 | $12,275 |
| Total Curr. Assets | $89,746 | $97,870 | $120,238 | $156,492 |
| Property Plant & Equip (Net) | $4,802 | $5,325 | $5,799 | $6,284 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $350 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1,334 | $1,684 | $1,674 | $1,642 |
| Total NC Assets | $6,486 | $7,009 | $7,473 | $7,926 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $96,232 | $104,879 | $127,711 | $164,418 |
| Liabilities | – | – | – | – |
| Payables | $5,392 | $2,597 | $5,872 | $5,107 |
| Short-Term Debt | $13,672 | $32,117 | $25,386 | $24,864 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $68,093 | $64,502 | $59,112 | $62,293 |
| Total Curr. Liab. | $87,157 | $99,216 | $90,370 | $92,264 |
| LT Debt | $182,751 | $158,501 | $161,317 | $169,660 |
| Deferred Rev, NC | $73,499 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $22,083 | $86,088 | $81,908 | $88,511 |
| Total NC Liab. | $278,333 | $244,589 | $243,225 | $258,171 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $6,008 | $7,634 | $7,412 | $7,150 |
| Total Liabilities | $365,490 | $343,805 | $333,595 | $350,435 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $13 | $13 | $13 | $13 |
| Retained Earnings | -$1,657,301 | -$1,624,174 | -$1,586,922 | -$1,563,460 |
| AOCI | -$259 | -$251 | -$321 | -$356 |
| Other Equity | $1,388,289 | $1,385,486 | $1,381,346 | $1,377,786 |
| Total Equity | -$269,258 | -$238,926 | -$205,884 | -$186,017 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $96,232 | $104,879 | $127,711 | $164,418 |
| Net Debt | $158,751 | $151,893 | $147,920 | $132,048 |